All news on the topic: Novartis International AG

745
Prostate cancer patients desperate for life-extending treatment denied access
Advanced prostate cancer patient Kevin Webber, who was given just two years to live when he was diagnosed in 2014 at the age of 49, urged all those involved, including NHS bosses and the drug manufacturer, to continue negotiations over Lutetium-177